Dermatofibrosarcoma: Clinical Trials

4 trials for Dermatofibrosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 11Terminated 1

Follow Dermatofibrosarcoma: new trials by email Literature Review of Dermatofibrosarcoma trials Research Report on Dermatofibrosarcoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma
Ontorpacept (TTI-621), Doxorubicin - Leiomyosarcoma
Phase 2TerminatedPfizer762021-06-222024-12-11
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)1512015-11-302022-08-23
Phase II Pazopanib Study in Advanced Dermatofibrosarcomas
Pazopanib - Dermatofibrosarcomas of DARIER FERRAND(DFSP)
Phase 2TerminatedAssistance Publique - Hôpitaux de Paris232010-07-012016-07-01
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
gene expression analysis, polymerase chain reaction, western blotting - Sarcoma
Phase 2TerminatedCity of Hope Medical Center12008-07-012014-07-11

Narrower conditions

Histiocytoma, Malignant Fibrous (2)  ·  Leiomyosarcoma (2)  ·  Neurofibrosarcoma (2)  ·  Sarcoma (2)  ·  Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Fibrosarcoma (1)  ·  Hemangiopericytoma, Malignant (1)  ·  Hemangiosarcoma (1)  ·  Liposarcoma (1)  ·  Malignant mesenchymal tumor (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma, Alveolar Soft Part (1)  ·  Sarcoma, Synovial (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective Tissue (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Fibrous Tissue (4)  ·  Fibrosarcoma (3)  ·  Neoplasms, Muscle Tissue (3)  ·  Histiocytoma (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Nerve Sheath Neoplasms (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neurofibroma (2)  ·  Neuromuscular Diseases (2)  ·  Peripheral Nervous System Diseases (2)

Interventions

pazopanib (2)  ·  Blotting, Western (1)  ·  Doxorubicin (1)  ·  Gene Expression Profiling (1)  ·  Neoadjuvant Therapy (1)  ·  Polymerase Chain Reaction (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  TTI-621 (1)  ·  sapanisertib (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  City of Hope Medical Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Pfizer (1)

Countries

United States (3)  ·  France (1)

Top investigators

Richard D. Pezner, MD (1)  ·  William D Tap (1)

Results publications

PMID 32956651

NIH funding

2009 (1), P30CA033572 (1), U10CA180821 (1)